Cogentia Healthcare Consulting

Name

Cogentia Healthcare Consulting

Legal name

Cogentia Healthcare Consulting Ltd

Website

https://cogentia.co.uk

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Headquarters

HQ city

Cambridge

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Consulting Services: Project-based consulting engagements covering market access strategy, HTA submissions, health economic modelling, evidence synthesis, pricing strategy, and access negotiations. Projects range from early discovery assessments through to mature product pricing adjustments.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Cogentia is a healthcare consulting firm that provides market access and HEOR (Health Economics and Outcomes Research) services to pharmaceutical, biotech, medical device, and diagnostic companies. Services span the full product lifecycle through six practice areas: Market Understanding, Opportunity Assessment, Strategy Development, Access Preparation, Access Negotiations, and Market Support, including HTA submissions for NICE, SMC, and other international bodies.

Product overview

Cogentia Healthcare Consulting is a market access and HEOR (Health Economics and Outcomes Research) consultancy that offers a unified suite of integrated consulting services rather than a software platform or product suite. The company's service offerings span the entire product lifecycle from early development through to market support, organized into six interconnected practice areas: Market Understanding, Opportunity Assessment, Strategy Development, Access Preparation, Access Negotiations, and Market Support. These services are complemented by an extensive publications library containing research on HTA submissions, economic modelling, market access strategy, gene therapy, and pricing across all therapeutic areas. The company works with pharmaceutical, device, diagnostic, biotech, and investor clients on projects ranging from early discovery assessment to mature product pricing optimization.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Understanding Services Research and analysis services to understand key issues, opportunities, challenges and barriers in bringing a product to market. Includes targeted literature reviews, epidemiology, burden of disease, market access landscape analysis, treatment pathways, competitive landscape, and payer/KOL research. For pharmaceutical, biotech, device and diagnostic companies.
• Opportunity Assessment Services Quantifies asset value to both payer and company by understanding value drivers, price range, market entry strategies and future market scenarios through competitive landscape analysis, forecasting, price ranging, early economic modelling, access pathway analysis, indication prioritisation, and licensing evaluations. For pharmaceutical and biotech companies.
• Strategy Development Services Creates coherent and holistic strategies incorporating needs of clinical and commercial stakeholders to maximise asset value. Includes strategic workshops, market access and pricing strategy, target product profiles, evidence gap analysis, real world evidence generation, advisory boards, and competitive tracking. For pharmaceutical and biotech clients.
• Access Preparation Services Prepares for pricing and reimbursement decision making and addresses evidence gaps through systematic literature reviews, economic and budget impact modelling, global value dossiers, value proposition development, policy/publication strategy, advisory boards, and patient access schemes. For pharmaceutical and biotech companies preparing for HTA submissions.
• Access Negotiations Services Secures optimal access across multiple launch markets through effective payer and wider stakeholder engagement including pricing and reimbursement negotiation, stakeholder engagement, training, mock negotiation workshops, patient access schemes, pricing applications, and HTA submissions. For pharmaceutical and biotech client teams.
• Market Support Services Maintains and optimises price and access, expands breadth of use, and maximises lifecycle management opportunities through dynamic marketplace strategy, lifecycle management, loss of exclusivity planning, competitive landscaping, publications, advocacy development, and affiliate workshops. For established pharmaceutical and biotech clients.

Quantifiable outcome

• Hundreds of successful projects completed since 2010
• +2 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Evidera (PPD): Evidera is a dedicated HEOR and market access consultancy serving pharma and biotech clients, now part of PPD/Thermo Fisher. It is a direct competitor in evidence synthesis, economic modelling, and HTA submissions, and a known prior employer of Cogentia's Project Director David Alderson.
• BresMed: BresMed is a UK-headquartered health economics consultancy providing HTA submissions, economic modelling and market access strategy. Directly comparable in service offering and UK therapeutic-area coverage, and listed as prior employer of Cogentia's Head of Health Economics.
• Dolon: Dolon is a specialist market access and pricing consultancy focused on rare diseases, HTA, and value communication. Directly comparable in scope and therapeutic-area emphasis, and named as a prior employer of a Cogentia market access specialist.
• Bridgehead International: Bridgehead International is a healthcare market access and commercial strategy consultancy serving pharma and biotech. Directly comparable in service mix, and listed as a prior employer of Cogentia's Project Director David Alderson.

Broad incumbents

• ZS Associates: ZS Associates is a large global management consulting and analytics firm with a substantial pharma strategy and market access practice. It competes for similar HTA and pricing engagements at greater scale, and is named as a prior employer of a Cogentia team member.
• IQVIA: IQVIA is the largest life sciences technology and services provider with extensive HEOR, RWE, and market access consulting capabilities. It competes for the same pharma advisory budgets at global scale, and is named as a prior employer of a Cogentia market access specialist.
• Putnam Associates: Putnam Associates is a strategic consulting firm serving biopharmaceutical clients on commercial strategy, pricing and market access. It competes for similar pharma strategy mandates and is comparable in boutique-to-mid-market positioning.
• Charles River Associates (CRA): CRA's Life Sciences practice provides economic, regulatory and commercial strategy consulting to pharma, including HTA and pricing support. Comparable in serving pharma and biotech clients with strategy and economics-led engagements.
• Health Economics and Outcomes Research (HEOR) at IPSOS (formerly GfK Health): IPSOS Healthcare (which absorbed GfK Health) operates a substantial HEOR and market access research practice globally. Directly comparable in payer/KOL research and evidence services, and GfK is named as a prior employer of Cogentia's Project Director.
• Accenture Life Sciences: Accenture's pharmaceutical and life sciences practice includes market access, HEOR and pricing strategy consulting. It competes for the same pharma advisory work at significantly greater scale, and is named as a prior employer of Cogentia's Head of Health Economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cogentia-healthcare-consulting

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cogentia Healthcare Consulting